Joshua A. Kazam

Director at Allogene Therapeutics · 3 reported transactions in 2 companies · latest report Jun 18, 2026

Their trades


Allogene TherapeuticsALLO	Exercised options — · 47,700 shares	Jun 18, 2026
Allogene TherapeuticsALLO	Exercised options — · 47,700 shares	Dec 18, 2025
Kronos BioKRON	Other $53.9K · 94,481 shares	Jun 20, 2025

Exercised optionsAllogene Therapeutics

Jun 18, 2026 · ALLO

47,700

Exercised optionsAllogene Therapeutics

Dec 18, 2025 · ALLO

47,700

OtherKronos Bio

Jun 20, 2025 · KRON

$53.9K

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.